Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04762329Not ApplicableCompleted

Manage My Pain at Chronic Pain Clinics

Role: collaborator

NCT03253549Not ApplicableCompleted

The SMArTVIEW, CoVeRed

Role: collaborator

NCT01752595Not ApplicableCompleted

The Music Activity INTervention for Adherence Improvement Through Neurological Entrainment

Role: collaborator

NCT01954849Phase 2Completed

Assessment of a Probiotic to Treat Gingivitis in Pediatric Patients

Role: collaborator

NCT00685438Completed

Ultraviolet Exposure, Antioxidant Use and Skin Erythema at Extreme High Altitude

Role: collaborator

All 5 trials loaded